Department of Internal Medicine 4, Nephrology and Hypertension, Saarland University Medical Centre, Homburg, Germany.
Department of Anaesthesiology, Intensive Care Medicine and Pain Medicine, University Hospital Münster, Münster, Germany.
Lancet. 2019 Aug 10;394(10197):488-496. doi: 10.1016/S0140-6736(19)30769-X. Epub 2019 Jun 12.
Cardiac surgery is associated with a high risk of postoperative acute kidney injury (AKI) and subsequent loss of kidney function. We explored the clinical utility of urinary dickkopf-3 (DKK3), a renal tubular stress marker, for preoperative identification of patients at risk for AKI and subsequent kidney function loss.
This observational cohort study included patients who had cardiac surgery in a derivation cohort and those who had cardiac surgery in a validation cohort (RenalRIP trial). The study comprised consecutive patients who had elective cardiac surgery at the Saarland University Medical Centre (Homburg, Germany; derivation cohort) and those undergoing elective cardiac surgery (selected on the basis of a Cleveland Clinical Foundation score of 6 or higher) who were enrolled in the prospective RenalRIP multicentre trial (validation cohort) and who were randomly assigned to remote ischaemic preconditioning or a sham procedure. The association between the ratio of preoperative urinary concentrations of DKK3 to creatinine (DKK3:creatinine) and postoperative AKI, defined according to the Kidney Disease Improving Global Outcomes criteria, and subsequent kidney function loss, as determined by estimated glomerular filtration rate, was assessed.
In the 733 patient in the derivation cohort, urinary concentrations of DKK3 to creatinine that were higher than 471 pg/mg were associated with significantly increased risk for AKI (odds ratio [OR] 1·65, 95% CI 1·10-2·47, p=0·015), independent of baseline kidney function. Compared with clinical and other laboratory measurements, urinary concentrations of DKK3:creatinine significantly improved AKI prediction (net reclassification improvement 0·32, 95% CI 0·23-0·42, p<0·0001). High urinary DKK3:creatinine concentrations were independently associated with significantly lower kidney function at hospital discharge and after a median follow-up of 820 days (IQR 733-910). In the RenalRIP trial, preoperative urinary DKK3:creatinine concentrations higher than 471 pg/mg were associated with a significantly higher risk for AKI (OR 1·94, 95% CI 1·08-3·47, p=0·026), persistent renal dysfunction (OR 6·67, 1·67-26·61, p=0·0072), and dialysis dependency (OR 13·57, 1·50-122·77, p=0·020) after 90 days compared with DKK3:creatinine concentrations of 471 pg/mg or less. Urinary DKK3:creatinine concentrations higher than 471 pg/mg were associated with significantly higher risk for AKI (OR 2·79, 95% CI 1·45-5·37) and persistent renal dysfunction (OR 3·82, 1·32-11·05) only in patients having a sham procedure, but not remote ischaemic preconditioning (AKI OR 1·35, 0·76-2·39 and persistent renal dysfunction OR 1·05, 0·12-9·45).
Preoperative urinary DKK3 is an independent predictor for postoperative AKI and for subsequent loss of kidney function. Urinary DKK3 might aid in the identification of patients in whom preventive treatment strategies are effective.
No study funding.
心脏手术与术后急性肾损伤(AKI)和随后肾功能丧失的风险较高有关。我们探讨了尿 dickkopf-3(DKK3)作为一种肾小管应激标志物,用于术前识别 AKI风险患者和随后肾功能丧失的临床应用。
这项观察性队列研究包括在推导队列中接受心脏手术的患者和在验证队列中接受心脏手术的患者(RenalRIP 试验)。该研究纳入了在德国萨尔兰大学医学中心(Homburg)接受择期心脏手术的连续患者(推导队列)和在克利夫兰临床基金会评分 6 分或更高的情况下接受择期心脏手术的患者(验证队列),这些患者参加了前瞻性 RenalRIP 多中心试验,并随机分配到远程缺血预处理或假手术组。评估术前尿 DKK3 与肌酐的浓度比值(DKK3:肌酐)与术后根据改善全球肾脏病预后组织标准定义的 AKI 之间的关联,以及通过估计肾小球滤过率确定的随后肾功能丧失。
在推导队列的 733 名患者中,尿 DKK3 与肌酐的浓度比高于 471 pg/mg 与 AKI 的风险显著增加相关(比值比[OR]1.65,95%置信区间[CI]1.10-2.47,p=0.015),与基线肾功能无关。与临床和其他实验室测量相比,尿 DKK3:肌酐的浓度显著提高了 AKI 预测能力(净重新分类改善 0.32,95%CI 0.23-0.42,p<0.0001)。高尿 DKK3:肌酐浓度与出院时和中位随访 820 天(733-910)时肾功能明显下降独立相关。在 RenalRIP 试验中,术前尿 DKK3:肌酐浓度高于 471 pg/mg 与 AKI 的风险显著增加相关(比值比[OR]1.94,95%CI 1.08-3.47,p=0.026)、持续肾功能障碍(OR 6.67,95%CI 1.67-26.61,p=0.0072)和透析依赖(OR 13.57,1.50-122.77,p=0.020)有关,而与 DKK3:肌酐浓度低于 471 pg/mg 相比。尿 DKK3:肌酐浓度高于 471 pg/mg 与 AKI(OR 2.79,95%CI 1.45-5.37)和持续肾功能障碍(OR 3.82,1.32-11.05)的风险显著增加相关,仅在接受假手术的患者中,而不是在接受远程缺血预处理的患者中(AKI OR 1.35,0.76-2.39 和持续肾功能障碍 OR 1.05,0.12-9.45)。
术前尿 DKK3 是术后 AKI 和随后肾功能丧失的独立预测因子。尿 DKK3 可能有助于识别需要预防治疗策略的患者。
无研究资金。